Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MINIONS

Financiado

Cerrado

Patient-specific Microstructural and radIobiological model for persoNalised exte...

Patient-specific Microstructural and radIobiological model for persoNalised external beam radiatIONn therapy in localised tumourS External-beam radiotherapy has been established as best practice care in different cancer cases, although current models applied in the clinics to tune the treatment plan dosimetry, as a function of the expected tumour response an... ver más

31/08/2029

POLIMI

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-09-01

ERC-2023-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

POLIMI

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DR THERAPAT Digital radiation therapy patient 5M€ Cerrado

TRIDOS Targeted Radiotherapy Internal Dosimetry A platform for ind... 173K€ Cerrado

RADRESPRO Radiation Response Models for Personalised Radiation Oncolog... 294K€ Cerrado

BIO-IRT Biologically individualized model based radiotherapy on the... 1M€ Cerrado

PLEC2022-009476 Advanced dosimetry for novel radiotherapy approaches in brai... 307K€ Cerrado

PRO-ORATICA PRedictive mOdeling Of RAdiaTion Induced CArdiotoxicity afte... 161K€ Cerrado

Duración del proyecto: 59 meses Fecha Inicio: 2024-09-01
Fecha Fin: 2029-08-31

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto External-beam radiotherapy has been established as best practice care in different cancer cases, although current models applied in the clinics to tune the treatment plan dosimetry, as a function of the expected tumour response and radiation-induced toxicity, do not make use of patient-specific information, but rely on radiobiological parameters typically derived from in-vitro experiments, thus abdicating from describing the in-vivo complexity of the pathology. MINIONS is a cutting-edge research programme that investigates and integrates a set of activities to implement patient-specific microstructural and radiobiological models in personalized radiotherapy treatment planning and adaptation towards a detailed description of tumour characteristics of each patient and thus significantly improved tumour control probability. The main challenge of MINIONS is to create, for the first time, a real-time patient-specific model able to describe the microscopic characteristic of the tumour and its interaction with the radiation beam. The scientific activities of MINIONS are to achieve and merge: (i) Monte-Carlo (MC) simulations of Diffusion Magnetic Resonance (DW-MR) signals and radiation-tissue interactions on a library of in-silico cellular substrates to obtain an integrated simulation platform; (ii) real-time Artificial Intelligence-based techniques to accelerate MC simulations and make them compatible with fast treatment planning and adaptation; (ii) advanced DW-MR imaging, to retrieve non-invasively the information required to feed the simulation platform for the implementation of patient-specific microstructural and radiobiological models. The design of in-vivo and ex-vivo tests allows validating the model performance and the collaboration of researchers, engineers and clinicians will drive the use of this innovative strategy in clinical routine, to increase survival and quality of life for a wide range of cancer patients.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores